{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:59:31Z","timestamp":1791104371894,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00415-010-5715-0","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T20:09:33Z","timestamp":1289851773000},"page":"276-283","source":"Crossref","is-referenced-by-count":29,"title":["Spectrum of addictions in Parkinson\u2019s disease: from dopamine dysregulation syndrome to impulse control disorders"],"prefix":"10.1007","volume":"257","author":[{"given":"Roberto","family":"Ceravolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Frosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaldo","family":"Bonuccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"5715_CR1","unstructured":"Jaffe JH (2001) Goodman and Gilman\u2019s the pharmacological basis of therapeutics. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) 8th edn. Pergamon, New York, pp 522\u2013573"},{"key":"5715_CR2","unstructured":"World Health Organization (1990) International statistical classification of diseases and related health problems\u201410th revision, World Health Organization, Geneva"},{"issue":"12","key":"5715_CR3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1360-0443.2005.01260.x","volume":"100","author":"R Spanagel","year":"2005","unstructured":"Spanagel R, Heilig M (2005) Addiction and its brain science. Addiction 100(12):1813\u20131822","journal-title":"Addiction"},{"issue":"1","key":"5715_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainresrev.2004.12.033","volume":"49","author":"CA Heidbreder","year":"2005","unstructured":"Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ et al (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Rev 49(1):77\u2013105","journal-title":"Brain Res Rev"},{"key":"5715_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.2005.00540.x","volume":"427","author":"RA Bressan","year":"2005","unstructured":"Bressan RA, Crippa JA (2005) The role of dopamine in reward and pleasure behaviour\u2014review of data from preclinical research. Acta Psychiatr Scand Suppl 427:14\u201321","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"5715_CR6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/30498","volume":"393","author":"MJ Koepp","year":"1998","unstructured":"Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T et al (1998) Evidence for striatal dopamine release during a video game. Nature 393:266\u2013268","journal-title":"Nature"},{"issue":"5335","key":"5715_CR7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278(5335):52\u201358","journal-title":"Science"},{"issue":"Suppl. 2","key":"5715_CR8","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","volume":"95","author":"TE Robinson","year":"2000","unstructured":"Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(Suppl. 2):S91\u2013S117","journal-title":"Addiction"},{"issue":"2","key":"5715_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24(2):97\u2013129","journal-title":"Neuropsychopharmacology"},{"key":"5715_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5715_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"AH Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, O\u2019Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397\u2013405","journal-title":"Mov Disord"},{"issue":"8","key":"5715_CR12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/mds.21296","volume":"22","author":"JM Miyasaki","year":"2007","unstructured":"Miyasaki JM, Al Hassan K, Lang AE, Voon V (2007) Punding prevalence in Parkinson\u2019s disease. Mov Disord 22(8):1179\u20131181","journal-title":"Mov Disord"},{"key":"5715_CR13","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington","edition":"4"},{"issue":"Suppl 2","key":"5715_CR14","first-page":"S93","volume":"64","author":"D Weintraub","year":"2008","unstructured":"Weintraub D (2008) Dopamine and impulse control disorders in Parkinson\u2019s disease. Ann Neurol 64(Suppl 2):S93\u2013S100","journal-title":"Ann Neurol"},{"key":"5715_CR15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.294.5544.980","volume":"294","author":"C Holden","year":"2001","unstructured":"Holden C (2001) \u2018Behavioral\u2019 addictions: do they exist? Science 294:980\u2013982","journal-title":"Science"},{"key":"5715_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","volume":"163","author":"CA Tamminga","year":"2006","unstructured":"Tamminga CA, Nestler EJ (2006) Pathological gambling: focusing on the addiction, not the activity. Am J Psychiatry 163:303\u2013312","journal-title":"Am J Psychiatry"},{"key":"5715_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","volume":"75","author":"JA Brewer","year":"2008","unstructured":"Brewer JA, Potenza MN (2008) The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 75:63\u201375","journal-title":"Biochem Pharmacol"},{"key":"5715_CR18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1176\/ajp.2006.163.10.1670","volume":"163","author":"E Hollander","year":"2006","unstructured":"Hollander E, Allen A (2006) Is compulsive buying a real disorder, and is it really compulsive? Am J Psychiatry 163:1670\u20131672","journal-title":"Am J Psychiatry"},{"issue":"1","key":"5715_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mds.20288","volume":"20","author":"FR Pezzella","year":"2005","unstructured":"Pezzella FR, Colosimo C, Vanacore N, Di Rezze S, Chianese M, Fabbrini G et al (2005) Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson\u2019s disease. Mov Disord 20(1):77\u201381","journal-title":"Mov Disord"},{"key":"5715_CR20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269881106073109","volume":"21","author":"N Giladi","year":"2007","unstructured":"Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C (2007) New-onset heightened interest or drive for gambling, shopping, eating, or sexual activity in patients with Parkinson\u2019s disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 21:501\u2013506","journal-title":"J Psychopharmacol"},{"key":"5715_CR21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","volume":"61","author":"E Driver-Dunckley","year":"2003","unstructured":"Driver-Dunckley E, Samanta J, Stacy M (2003) Pathological gambling associated with dopamine agonist therapy in Parkinson\u2019s disease. Neurology 61:422\u2013423","journal-title":"Neurology"},{"key":"5715_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archneur.63.2.298-a","volume":"63","author":"C Lu","year":"2006","unstructured":"Lu C, Bharmal A, Suchowersky O (2006) Gambling and Parkinson\u2019s disease. Arch Neurol 63:298","journal-title":"Arch Neurol"},{"key":"5715_CR23","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/mds.21110","volume":"21","author":"KA Grosset","year":"2006","unstructured":"Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, Grosset DG (2006) Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 21:2206\u20132208","journal-title":"Mov Disord"},{"key":"5715_CR24","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, Lang AE, Miyasaki J (2006) Prospective prevalence of pathological gambling and medication association in Parkinson disease. Neurology 66:1750\u20131752","journal-title":"Neurology"},{"key":"5715_CR25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"D Weintraub","year":"2006","unstructured":"Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969\u2013973","journal-title":"Arch Neurol"},{"key":"5715_CR26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67:1254\u20131257","journal-title":"Neurology"},{"key":"5715_CR27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mds.21872","volume":"23","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:411\u2013415","journal-title":"Mov Disord"},{"key":"5715_CR28","first-page":"5","volume":"55","author":"GA Christenson","year":"1994","unstructured":"Christenson GA, Faber RJ, deZwaan M (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55:5\u201311","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"5715_CR29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10899-008-9099-3","volume":"24","author":"D Crockford","year":"2008","unstructured":"Crockford D, Quickfall J, Currie S, Furtado S, Suchowersky O, El-Guebaly N (2008) Prevalence of problem and pathological gambling in Parkinson\u2019s disease. J Gambl Stud 24(4):411\u2013422","journal-title":"J Gambl Stud"},{"key":"5715_CR30","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","volume":"21","author":"M Avanzi","year":"2006","unstructured":"Avanzi M, Baratti M, Cabrini S, Bonf\u00e0 F, Brighetti G, Uber E (2006) Prevalence of pathological gambling in patients with Parkinson\u2019s disease. Mov Disord 21:2068\u20132072","journal-title":"Mov Disord"},{"key":"5715_CR31","unstructured":"Ceravolo R, Frosini D, Rossi C, Nicoletti V, Berti C, Unti E, et al. (2009) Prevalence of Impulse control disorders in Parkinson\u2019s disease. Neurol Sci 30(Suppl):S456"},{"key":"5715_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1017459","volume":"16","author":"HP Vogel","year":"1983","unstructured":"Vogel HP, Shiffer R (1983) Hypersexuality: a complication of dopaminergic therapy in Parkinson\u2019s disease. Pharmacopsychiatria 16:107\u2013110","journal-title":"Pharmacopsychiatria"},{"key":"5715_CR33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1192\/bjp.153.6.833","volume":"153","author":"NS Harvey","year":"1988","unstructured":"Harvey NS (1988) Serial cognitive profiles in levodopa-induced hypersexuality. Br J Psychiatry 153:833\u2013836","journal-title":"Br J Psychiatry"},{"key":"5715_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-198910000-00002","volume":"12","author":"RJ Uitti","year":"1989","unstructured":"Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B (1989) Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 12:375\u2013383","journal-title":"Clin Neuropharmacol"},{"key":"5715_CR35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.870130326","volume":"13","author":"JD O\u2019Sullivan","year":"1998","unstructured":"O\u2019Sullivan JD, Hughes AJ (1998) Apomorphine-induced penile erections in Parkinson\u2019s disease. Mov Disord 13:536\u2013539","journal-title":"Mov Disord"},{"key":"5715_CR36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","volume":"11","author":"KJ Klos","year":"2005","unstructured":"Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE (2005) Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat Disord 11:381\u2013386","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"5715_CR37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","volume":"2","author":"AD Lawrence","year":"2003","unstructured":"Lawrence AD, Evans AH, Lees AJ (2003) Compulsive use of dopamine replacement therapy in Parkinson\u2019s disease: reward systems gone awry? Lancet Neurol 2(10):595\u2013604","journal-title":"Lancet Neurol"},{"issue":"3","key":"5715_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drugalcdep.2004.06.005","volume":"76","author":"J Bearn","year":"2004","unstructured":"Bearn J, Evans A, Kelleher M, Turner K, Lees A (2004) Recognition of a dopamine replacement therapy dependence syndrome in Parkinson\u2019s disease: a pilot study. Drug Alcohol Depend 76(3):305\u2013310","journal-title":"Drug Alcohol Depend"},{"key":"5715_CR39","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","volume":"22","author":"DA Gallagher","year":"2007","unstructured":"Gallagher DA, O\u2019Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson\u2019s disease: risk factors and differences from dopamine dysregulation. Mov Disord 22:1757\u20131763","journal-title":"Mov Disord"},{"key":"5715_CR40","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","volume":"65","author":"AH Evans","year":"2005","unstructured":"Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65:1570\u20131574","journal-title":"Neurology"},{"key":"5715_CR41","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2007.01.009","volume":"14","author":"A Singh","year":"2007","unstructured":"Singh A, Kandimala G, Dewey RB Jr, O\u2019Suilleabhain P (2007) Risk factors for pathologic gambling and other compulsions among Parkinson\u2019s disease patients taking dopamine agonists. J Clin Neurosci 14:1178\u20131181","journal-title":"J Clin Neurosci"},{"key":"5715_CR42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212\u2013216","journal-title":"Arch Neurol"},{"key":"5715_CR43","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","volume":"67","author":"G Pontone","year":"2006","unstructured":"Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67:1258\u20131261","journal-title":"Neurology"},{"issue":"6","key":"5715_CR44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.22472","volume":"24","author":"G Santangelo","year":"2009","unstructured":"Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P (2009) Cognitive dysfunctions and pathological gambling in patients with Parkinson\u2019s disease. Mov Disord 24(6):899\u2013905","journal-title":"Mov Disord"},{"key":"5715_CR45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","volume":"62","author":"ML Dodd","year":"2005","unstructured":"Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377\u20131381","journal-title":"Arch Neurol"},{"issue":"5","key":"5715_CR46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","volume":"30","author":"ED Driver-Dunckley","year":"2007","unstructured":"Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH (2007) Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 30(5):249\u2013255","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"5715_CR47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00008571-199506000-00001","volume":"5","author":"K Blum","year":"1995","unstructured":"Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE (1995) Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 5(3):121\u2013141","journal-title":"Pharmacogenetics"},{"issue":"4","key":"5715_CR48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G","volume":"88","author":"DE Comings","year":"1999","unstructured":"Comings DE, Gonzalez N, Wu S, Gade R, Muhleman D, Saucier G, Johnson P, Verde R, Rosenthal RJ, Lesieur HR, Rugle LJ, Miller WB, MacMurray JP (1999) Studies of the 48\u00a0bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 88(4):358\u2013368","journal-title":"Am J Med Genet"},{"issue":"5","key":"5715_CR49","first-page":"345","volume":"7","author":"I P\u00e9rez de Castro","year":"1997","unstructured":"P\u00e9rez de Castro I, Ib\u00e1\u00f1ez A, Torres P, S\u00e1iz-Ruiz J, Fern\u00e1ndez-Piqueras J (1997) Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 7(5):345\u2013348","journal-title":"Pharmacogenetics"},{"key":"5715_CR50","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","volume":"24","author":"JY Lee","year":"2009","unstructured":"Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson\u2019s disease. Mov Disord 24:1803\u20131810","journal-title":"Mov Disord"},{"issue":"5","key":"5715_CR51","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/ana.20822","volume":"59","author":"AH Evans","year":"2006","unstructured":"Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P (2006) Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 59(5):852\u2013858","journal-title":"Ann Neurol"},{"issue":"2","key":"5715_CR52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","volume":"8","author":"J Reuter","year":"2005","unstructured":"Reuter J, Raedler T, Rose M, Hand I, Gl\u00e4scher J, B\u00fcchel C (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8(2):147\u2013148","journal-title":"Nat Neurosci"},{"issue":"12","key":"5715_CR53","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archneur.65.12.1604","volume":"65","author":"R Cilia","year":"2008","unstructured":"Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, Pezzoli G, Antonini A (2008) Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 65(12):1604\u20131611","journal-title":"Arch Neurol"},{"key":"5715_CR54","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132:1376\u20131385","journal-title":"Brain"},{"issue":"2","key":"5715_CR55","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1353-8020(09)70213-5","volume":"15","author":"D Frosini","year":"2009","unstructured":"Frosini D, Pesaresi I, Rossi C, De Feo P, Cosottini M, Bonuccelli U, Ceravolo R (2009) Parkinson\u2019s disease and pathological gambling: results from a fMRI study invesigating cue-induced brain activity. Parkinsonism Rel Dis 15(2):S52","journal-title":"Parkinsonism Rel Dis"},{"key":"5715_CR56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"E Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D (2008) Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:75\u201380","journal-title":"Mov Disord"},{"key":"5715_CR57","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1345\/aph.1A412","volume":"36","author":"FJ Jimenez-Jimenez","year":"2002","unstructured":"Jimenez-Jimenez FJ, Sayed Y, Garcia-Soldevilla MA, Barcenilla B (2002) Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 36:1178\u20131179","journal-title":"Ann Pharmacother"},{"key":"5715_CR58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00002826-200105000-00009","volume":"24","author":"U Gschwandtner","year":"2001","unstructured":"Gschwandtner U, Aston J, Renaud S, Fuhr P (2001) Pathologic gambling in patients with Parkinson\u2019s disease. Clin Neuropharmacol 24:170\u2013172","journal-title":"Clin Neuropharmacol"},{"key":"5715_CR59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10401230490281366","volume":"16","author":"JE Grant","year":"2004","unstructured":"Grant JE, Potenza MN (2004) Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry 16:27\u201334","journal-title":"Ann Clin Psychiatry"},{"key":"5715_CR60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","volume":"163","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A (2006) Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303\u2013312","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5715-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5715-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5715-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T07:23:42Z","timestamp":1711956222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5715-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":60,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["5715"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5715-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}